Natural Alternatives International (NASDAQ:NAII) Now Covered by StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a research note issued on Monday. The brokerage set a “buy” rating on the stock.

Natural Alternatives International Stock Performance

NASDAQ NAII opened at $4.21 on Monday. Natural Alternatives International has a 1-year low of $4.02 and a 1-year high of $7.26. The company has a market capitalization of $26.10 million, a P/E ratio of -2.92 and a beta of 0.61. The business has a 50 day moving average price of $4.35 and a 200 day moving average price of $5.12. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.56 and a quick ratio of 1.50.

Institutional Trading of Natural Alternatives International

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC lifted its position in shares of Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 45,062 shares of the company’s stock after buying an additional 2,915 shares during the quarter. Geode Capital Management LLC owned approximately 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent quarter. 32.40% of the stock is currently owned by institutional investors.

Natural Alternatives International Company Profile

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.